Bausch + Lomb targets 5-7% revenue CAGR, ~23% EBITDA margin; pipeline peak sales ~$7B

Bausch & Lomb Corp

Targets 5-7% constant currency revenue CAGR 2025-2028.
Adjusted EBITDA margin (excl. Acq. IPR&D) target of ~23% in 2028.
Double-digit adjusted EPS growth (excl. Acq. IPR&D) expected 2026-2028.
Pipeline products projected peak sales of ~$7 billion; key launches include ELIOS MIGS (US 2H 2026) and PreserVision AREDS3 (1H 2026).
Net leverage target of ~3.5x by end of 2028; 2025 guidance reaffirmed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.